USD 17.18
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 34.85 Billion | 244.25 Million | 200.7 Million | 263.47 Million | 264.75 Million | 37.55 Billion |
Net Income | 12.24 Billion | 110.18 Million | 117.67 Million | 51.51 Million | 102.38 Million | 13.5 Billion |
Depreciation & Amortization | 20.63 Billion | 154.71 Million | 167.75 Million | 192.22 Million | 195.72 Million | 19.56 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 4.2 Billion | -25.68 Million | -98.63 Million | 19.08 Million | -36.36 Million | 4.78 Billion |
Other non-cash items | 36.62 Billion | 5.04 Million | 13.91 Million | 651.58 Thousand | 3.01 Million | 36.14 Billion |
Investing Cash Flow | -20.31 Billion | -176.37 Million | -166.64 Million | -170.15 Million | -227.27 Million | -23.04 Billion |
Investments in PPE | -20.37 Billion | -169.87 Million | -155.74 Million | -164.59 Million | -227.33 Million | -22.18 Billion |
Acquisitions | 1.74 Billion | 466.67 Thousand | 386.1 Thousand | 153.84 Thousand | 7.57 Million | 17 Million |
Investment purchases | -241 Million | -7527.00 | -8215.00 | -9049.77 | -18.52 Thousand | -4 Million |
Sales/Maturities of investments | - | - | - | -9050.23 | -9264.00 | -9036.00 |
Other Investing Activities | -1.44 Billion | -6.95 Million | -11.27 Million | -5.69 Million | -7.49 Million | -872 Million |
Financing Cash Flow | -11.89 Billion | -87.65 Million | -82.02 Million | 139.85 Million | -60.71 Million | -6.89 Billion |
Debt repayment | -54.69 Billion | -57.31 Million | -59.26 Million | -165.48 Million | -26.99 Million | -4.18 Billion |
Dividends payments | -4.55 Billion | -4.09 Billion | -2.72 Billion | -2.72 Billion | -3.63 Billion | -2.72 Billion |
Common Stock Repurchased | -62.13 Billion | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 96 Million | 489.25 Thousand | -353.24 Thousand | 330.02 Million | -27.79 Thousand | 25 Million |
Accounts receivables | 3.15 Billion | 5.16 Million | 10.35 Million | -36.09 Million | -28.11 Million | 10.85 Billion |
Accounts payables | -2.29 Billion | -18.99 Million | -59.69 Million | 16.64 Million | 44.15 Million | -9.17 Billion |
Inventory | 1.56 Billion | 9.29 Million | -54.81 Million | -3.58 Million | -23.94 Million | 988 Million |
Other working capital | 1.78 Billion | -21.15 Million | 5.52 Million | 42.12 Million | -28.46 Million | 2.11 Billion |
Cash at beginning of period | 63.02 Billion | 538.56 Million | 634.26 Million | 410.3 Million | 426.36 Million | 39.43 Billion |
Cash at end of period | 68.29 Billion | 474.38 Million | 538.56 Million | 634.26 Million | 410.3 Million | 47.19 Billion |
Capital Expenditure | -20.37 Billion | -169.87 Million | -155.74 Million | -164.59 Million | -227.33 Million | -22.18 Billion |
Effect of forex changes on cash | 2.62 Billion | 91 Million | 1.31 Billion | 25 Million | -389 Million | 134 Million |
Net cash flow / Change in cash | 5.27 Billion | -64.17 Million | -95.69 Million | 223.96 Million | -16.06 Million | 7.75 Billion |
Free Cash Flow | 14.48 Billion | 74.38 Million | 44.96 Million | 98.87 Million | 37.42 Million | 15.37 Billion |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 12.24 Billion | 1.46 Billion | 4.06 Billion | 4.21 Billion | 2.5 Billion | 110.18 Million |
Depreciation & Amortization | 20.63 Billion | - | - | - | - | 154.71 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 4.2 Billion | - | - | - | - | -25.68 Million |
Other non-cash items | 36.62 Billion | -1.46 Billion | -4.06 Billion | -4.21 Billion | -2.5 Billion | 5.04 Million |
Investing Cash Flow | -20.31 Billion | - | - | - | - | -176.37 Million |
Investments in PPE | -20.37 Billion | - | - | - | - | -169.87 Million |
Acquisitions | 1.74 Billion | - | - | - | - | 466.67 Thousand |
Investment purchases | -241 Million | - | - | - | - | -7527.00 |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.44 Billion | - | - | - | - | -6.95 Million |
Financing Cash Flow | -11.89 Billion | - | - | - | - | -87.65 Million |
Debt repayment | -54.69 Billion | - | - | - | - | -57.31 Million |
Dividends payments | -4.55 Billion | - | - | - | - | -4.09 Billion |
Common Stock Repurchased | -62.13 Billion | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 96 Million | - | - | - | - | 489.25 Thousand |
Accounts receivables | 3.15 Billion | - | - | - | - | 5.16 Million |
Accounts payables | -2.29 Billion | - | - | - | - | -18.99 Million |
Inventory | 1.56 Billion | - | - | - | - | 9.29 Million |
Other working capital | 1.78 Billion | - | - | - | - | -21.15 Million |
Cash at beginning of period | 63.02 Billion | - | - | - | - | 538.56 Million |
Cash at end of period | 68.29 Billion | - | - | - | - | 474.38 Million |
Capital Expenditure | -20.37 Billion | - | - | - | - | -169.87 Million |
Effect of forex changes on cash | 2.62 Billion | - | - | - | - | 91 Million |
Net cash flow / Change in cash | 5.27 Billion | - | - | - | - | -64.17 Million |
Free Cash Flow | 14.48 Billion | - | - | - | - | 74.38 Million |
FFARMS
CVE
TECO
TCNAF
0267
CARL-A